LUDWIG MAXIMILIANS UNIV MUNCHEN has a total of 13 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Canada, Israel and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CANCER RESEARCH TECH LTD, H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC and ALLELIX BIOPHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | Israel | 3 | |
#3 | Australia | 2 | |
#4 | Republic of Korea | 1 | |
#5 | Taiwan | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Chemical engineering | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Tavan Paul | 2 |
#2 | Bertsch Uwe | 2 |
#3 | Groschup Martin H | 2 |
#4 | Giese Armin | 2 |
#5 | Leonov Andrei | 2 |
#6 | Wagner Jens | 2 |
#7 | Griesinger Christian | 2 |
#8 | Kretzschmar Hans | 2 |
#9 | Geissen Markus | 2 |
#10 | Ryazanov Sergey | 2 |
Publication | Filing date | Title |
---|---|---|
TW201902911A | Gene therapy for the treatment of CNGB1-associated retinitis pigmentosa |